Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E1HF
|
||||
Former ID |
DIB004540
|
||||
Drug Name |
FFC-14A
|
||||
Synonyms |
KP 1019; KP-692; HInd(RuInd2CI4), University of Vienna; KP-1019 (anhydrous); Ruthenium(III) complex, Faustus Forschung
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 1 | [545763] | ||
Company |
Faustus Forschungs Cie Translational Cancer Research GmbH
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
n1[nH]c2c(c1)cccc2.n1[nH]c2c(c1)cccc2.n1[nH]c2c(c1)cccc<br />2.[Ru-](Cl)(Cl)(Cl)Cl
|
||||
Target and Pathway | |||||
Target(s) | Human DNA | Target Info | Binder | [527657] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.